摘要
目的:研究前列腺癌组织VEGFR-3(flt4)和CD31的表达与前列腺癌中的新生血管、淋巴管的生成及肿瘤转移的关系。方法:用EnVisionTM免疫组织化学及图像分析法,检测前列腺癌组织VEGFR-3和CD31表达;用Weidner最高血管密度计数法,计数阳性淋巴管数(MLC)和微血管密度(MVD)。结果:前列腺癌组织MLC(8·26±2·13/mm2)和MVD(75·06±14·38/mm2)显著高于癌周组织的MLC(4·75±1·19/mm2)和MVD(31·33±15·47/mm2),两者比较具有显著性差异(P<0·01)。VEGFR-3和CD31的表达之间存在正相关(P<0·05,r=0·6418)。有淋巴转移和TNM分期Ⅲ、Ⅳ期的前列腺癌患者MLC、MVD分别高于无淋巴转移和Ⅰ、Ⅱ期患者,均具有显著性差异(P<0·01,P<0·05)。前列腺癌在不同的组织学分级的差异,无统计学意义(P>0·05)。结论:前列腺癌组织中的VEGFR-3和CD31表达水平与肿瘤的转移密切相关;前列腺癌组织MLC和MVD的显著增高,提示肿瘤组织有淋巴管和血管的生成,可作为判断肿瘤转移的生物学指标。
Objective:To investigate the relationship between the expression of vascular endothelial growth factor receptor-3(VEGFR-3)and CD 31 and to expound the metastasis mechanism of prostate cancer. Methods: VEGFR-3 and CD 31 expression were examined by immunohistochemical methods of Envision,VEGFR-3 positive microlymphatic count(MLC)and microvessel density( MVD) were appraised by the Weidner highest microvessel density and imageanalysis. Results: Both MLC and MVD in prostate cancer were higher than MLC,MVD in normal tissues(P〈0.01). There was significant correlation between the expression of VEGFR. 3 and CD 31 (P〈0.05,r=0. 6418). In prostate cancer,MLC and MVD were higher in the cases of clinical stage Ⅲ~Ⅳ and with lymphatic metastasis than those of clinical stage Ⅰ~Ⅱ and without lymphatic metastasis respectively(P〈0.05), There were no significant differences between MLC, MVD and histologic type,histologie grade(differentiation)in prostate cancer(P〉0.05). Conclutions: VEGFR-3 and CD 31 expression correlated significantly with metastasis, MLC and MVD might predict peritumoral lymphangiogenesis,angiogenesis,which may be as a biologic marker of metastasis in prostate cancer.
出处
《浙江中医学院学报》
2005年第5期14-17,共4页
Journal of Zhejiang College of Traditional Chinese Medicine
基金
浙江省教育厅科研基金资助项目(20040540)